PGN-EDODM1
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for PGN-EDODM1, covering 2026-02-13 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE) [Phase 2]